 Regie Lyn Santos-Cortez
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otitis Media | 12 | 2022 | 146 | 6.750 |
Why?
| | Hearing Loss | 25 | 2021 | 186 | 5.190 |
Why?
| | Genes, Recessive | 27 | 2021 | 73 | 3.610 |
Why?
| | Mutation, Missense | 15 | 2020 | 300 | 3.020 |
Why?
| | Pedigree | 51 | 2021 | 485 | 2.640 |
Why?
| | alpha-Macroglobulins | 4 | 2019 | 24 | 2.370 |
Why?
| | Microbiota | 9 | 2022 | 656 | 2.300 |
Why?
| | Mutation | 26 | 2021 | 3457 | 2.050 |
Why?
| | Ear, Middle | 6 | 2022 | 92 | 2.000 |
Why?
| | Genetic Variation | 11 | 2021 | 926 | 1.970 |
Why?
| | Genetic Predisposition to Disease | 24 | 2021 | 2275 | 1.870 |
Why?
| | Fucosyltransferases | 2 | 2022 | 30 | 1.490 |
Why?
| | Cochlear Implantation | 3 | 2021 | 81 | 1.430 |
Why?
| | Sequence Analysis, DNA | 16 | 2020 | 755 | 1.330 |
Why?
| | Cochlear Implants | 3 | 2020 | 91 | 1.290 |
Why?
| | Consanguinity | 20 | 2019 | 49 | 1.270 |
Why?
| | Membrane Proteins | 9 | 2021 | 1055 | 1.230 |
Why?
| | Exome | 16 | 2020 | 220 | 1.130 |
Why?
| | Deafness | 5 | 2020 | 79 | 1.130 |
Why?
| | Gene Frequency | 8 | 2019 | 513 | 1.020 |
Why?
| | RNA, Ribosomal, 16S | 4 | 2022 | 514 | 1.010 |
Why?
| | Nasopharynx | 2 | 2022 | 64 | 1.000 |
Why?
| | Alleles | 8 | 2019 | 832 | 0.890 |
Why?
| | Aortic Aneurysm, Thoracic | 8 | 2016 | 121 | 0.890 |
Why?
| | Pakistan | 16 | 2019 | 74 | 0.870 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.860 |
Why?
| | Cholesteatoma | 1 | 2022 | 13 | 0.850 |
Why?
| | Haemophilus Infections | 1 | 2022 | 31 | 0.830 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 13 | 0.810 |
Why?
| | Connexins | 6 | 2016 | 50 | 0.800 |
Why?
| | Membrane Transport Proteins | 4 | 2017 | 137 | 0.790 |
Why?
| | Temporal Bone | 1 | 2021 | 43 | 0.780 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.760 |
Why?
| | Plasminogen | 1 | 2020 | 34 | 0.750 |
Why?
| | Otitis Media with Effusion | 1 | 2019 | 20 | 0.710 |
Why?
| | ABO Blood-Group System | 1 | 2019 | 35 | 0.710 |
Why?
| | Intellectual Disability | 2 | 2018 | 136 | 0.710 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 239 | 0.700 |
Why?
| | Male | 61 | 2021 | 57801 | 0.690 |
Why?
| | Philippines | 5 | 2019 | 55 | 0.670 |
Why?
| | Genetic Markers | 3 | 2018 | 348 | 0.660 |
Why?
| | Female | 60 | 2021 | 61565 | 0.650 |
Why?
| | Genotype | 16 | 2019 | 1882 | 0.640 |
Why?
| | Acid Ceramidase | 1 | 2017 | 1 | 0.620 |
Why?
| | Keloid | 1 | 2017 | 7 | 0.620 |
Why?
| | Ear, Inner | 3 | 2016 | 39 | 0.610 |
Why?
| | Albinism, Oculocutaneous | 1 | 2017 | 6 | 0.600 |
Why?
| | Homozygote | 9 | 2018 | 190 | 0.600 |
Why?
| | Genes, Duplicate | 1 | 2016 | 3 | 0.590 |
Why?
| | Humans | 76 | 2022 | 118974 | 0.590 |
Why?
| | Neurodevelopmental Disorders | 1 | 2018 | 116 | 0.580 |
Why?
| | Down-Regulation | 1 | 2019 | 627 | 0.570 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2016 | 13 | 0.560 |
Why?
| | Child | 20 | 2021 | 19129 | 0.550 |
Why?
| | Hearing Loss, Sensorineural | 4 | 2021 | 60 | 0.550 |
Why?
| | Genetic Linkage | 13 | 2018 | 321 | 0.540 |
Why?
| | Haplotypes | 8 | 2019 | 473 | 0.530 |
Why?
| | Hair Cells, Auditory | 2 | 2021 | 39 | 0.520 |
Why?
| | DNA, Bacterial | 1 | 2016 | 314 | 0.520 |
Why?
| | Gene Duplication | 1 | 2015 | 64 | 0.520 |
Why?
| | Phenotype | 14 | 2021 | 3003 | 0.490 |
Why?
| | Adenylyl Cyclases | 1 | 2014 | 86 | 0.480 |
Why?
| | Child, Preschool | 12 | 2021 | 9491 | 0.470 |
Why?
| | Lysine-tRNA Ligase | 1 | 2013 | 2 | 0.470 |
Why?
| | Myosins | 3 | 2021 | 130 | 0.460 |
Why?
| | Lod Score | 11 | 2016 | 75 | 0.460 |
Why?
| | Cyclic AMP | 1 | 2014 | 242 | 0.450 |
Why?
| | Environmental Exposure | 1 | 2016 | 405 | 0.430 |
Why?
| | Genetic Loci | 6 | 2014 | 281 | 0.430 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1597 | 0.430 |
Why?
| | Chromosomes, Human, Pair 19 | 2 | 2016 | 25 | 0.420 |
Why?
| | Mice | 11 | 2022 | 15520 | 0.420 |
Why?
| | Animals | 16 | 2022 | 33381 | 0.390 |
Why?
| | Chromosomes, Human, Pair 4 | 2 | 2006 | 29 | 0.350 |
Why?
| | Finland | 2 | 2019 | 71 | 0.350 |
Why?
| | Adolescent | 17 | 2019 | 18480 | 0.350 |
Why?
| | Polydactyly | 2 | 2019 | 6 | 0.350 |
Why?
| | Codon, Nonsense | 4 | 2018 | 38 | 0.350 |
Why?
| | Family Health | 6 | 2019 | 201 | 0.340 |
Why?
| | Toes | 2 | 2019 | 26 | 0.340 |
Why?
| | Genetic Association Studies | 6 | 2019 | 371 | 0.340 |
Why?
| | Fingers | 2 | 2019 | 83 | 0.330 |
Why?
| | Amino Acid Sequence | 9 | 2020 | 2071 | 0.320 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 3 | 2017 | 5 | 0.320 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 4908 | 0.310 |
Why?
| | Adult | 20 | 2020 | 31512 | 0.310 |
Why?
| | Genes, Dominant | 2 | 2011 | 96 | 0.310 |
Why?
| | Connexin 26 | 5 | 2014 | 8 | 0.300 |
Why?
| | Sequence Analysis, RNA | 2 | 2020 | 409 | 0.300 |
Why?
| | Genomics | 3 | 2020 | 706 | 0.280 |
Why?
| | COS Cells | 2 | 2018 | 184 | 0.280 |
Why?
| | Infant | 7 | 2021 | 8293 | 0.270 |
Why?
| | Exons | 5 | 2018 | 307 | 0.270 |
Why?
| | Frameshift Mutation | 3 | 2015 | 28 | 0.260 |
Why?
| | Bacteria | 2 | 2022 | 757 | 0.250 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 69 | 0.250 |
Why?
| | Molecular Sequence Data | 7 | 2016 | 2871 | 0.250 |
Why?
| | Serine Endopeptidases | 2 | 2018 | 105 | 0.250 |
Why?
| | Fasting | 1 | 2006 | 264 | 0.250 |
Why?
| | Cochlea | 2 | 2015 | 88 | 0.230 |
Why?
| | Models, Molecular | 4 | 2016 | 1435 | 0.230 |
Why?
| | Zebrafish | 4 | 2016 | 434 | 0.230 |
Why?
| | Chromosome Mapping | 8 | 2019 | 510 | 0.220 |
Why?
| | Intracranial Aneurysm | 2 | 2016 | 99 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2016 | 453 | 0.210 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 50 | 0.210 |
Why?
| | ADAMTS1 Protein | 1 | 2021 | 2 | 0.200 |
Why?
| | Carboxy-Lyases | 1 | 2021 | 9 | 0.200 |
Why?
| | RNA Splice Sites | 2 | 2018 | 35 | 0.200 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2019 | 404 | 0.200 |
Why?
| | HEK293 Cells | 3 | 2018 | 625 | 0.200 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2021 | 45 | 0.200 |
Why?
| | Oncogene Proteins | 1 | 2021 | 52 | 0.200 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2020 | 2062 | 0.190 |
Why?
| | Young Adult | 9 | 2020 | 10793 | 0.190 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.190 |
Why?
| | Base Sequence | 2 | 2015 | 2159 | 0.190 |
Why?
| | DNA Demethylation | 1 | 2020 | 2 | 0.190 |
Why?
| | Mouth | 1 | 2020 | 74 | 0.190 |
Why?
| | Dioxygenases | 1 | 2020 | 26 | 0.180 |
Why?
| | Lipoxygenase | 2 | 2017 | 12 | 0.180 |
Why?
| | Ichthyosis, Lamellar | 2 | 2017 | 10 | 0.180 |
Why?
| | Middle Aged | 11 | 2020 | 27617 | 0.170 |
Why?
| | Saliva | 1 | 2020 | 188 | 0.170 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 551 | 0.170 |
Why?
| | Ciliopathies | 1 | 2018 | 5 | 0.170 |
Why?
| | Acute Disease | 2 | 2019 | 940 | 0.170 |
Why?
| | Protein Conformation | 3 | 2020 | 848 | 0.170 |
Why?
| | Tumor Suppressor Proteins | 1 | 2021 | 289 | 0.170 |
Why?
| | Retinitis Pigmentosa | 1 | 2018 | 17 | 0.170 |
Why?
| | Chromosome Segregation | 1 | 2018 | 35 | 0.170 |
Why?
| | Arthrogryposis | 2 | 2015 | 6 | 0.170 |
Why?
| | Hypotrichosis | 1 | 2018 | 1 | 0.160 |
Why?
| | Ichthyosis | 1 | 2018 | 12 | 0.160 |
Why?
| | Genetic Diseases, Inborn | 1 | 2018 | 46 | 0.160 |
Why?
| | Disease Susceptibility | 1 | 2020 | 331 | 0.160 |
Why?
| | RNA Splicing Factors | 1 | 2018 | 50 | 0.160 |
Why?
| | DEAD-box RNA Helicases | 1 | 2018 | 56 | 0.160 |
Why?
| | Nails, Malformed | 1 | 2017 | 5 | 0.160 |
Why?
| | Skin Diseases, Genetic | 1 | 2017 | 10 | 0.160 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 142 | 0.160 |
Why?
| | Family | 2 | 2018 | 585 | 0.160 |
Why?
| | Cytoskeletal Proteins | 2 | 2015 | 146 | 0.150 |
Why?
| | Polymorphism, Genetic | 3 | 2005 | 642 | 0.150 |
Why?
| | Optic Atrophy | 1 | 2016 | 11 | 0.150 |
Why?
| | Linkage Disequilibrium | 2 | 2016 | 273 | 0.150 |
Why?
| | Rare Diseases | 1 | 2017 | 113 | 0.150 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 20 | 0.150 |
Why?
| | Dystonic Disorders | 1 | 2016 | 17 | 0.150 |
Why?
| | Developmental Disabilities | 1 | 2020 | 247 | 0.150 |
Why?
| | Otoscopy | 1 | 2016 | 8 | 0.150 |
Why?
| | Recurrence | 1 | 2019 | 975 | 0.140 |
Why?
| | Blood Glucose | 1 | 2006 | 1939 | 0.140 |
Why?
| | Population Groups | 1 | 2016 | 58 | 0.140 |
Why?
| | Trichothiodystrophy Syndromes | 1 | 2016 | 1 | 0.140 |
Why?
| | Marfan Syndrome | 2 | 2016 | 42 | 0.140 |
Why?
| | Fibrillin-1 | 1 | 2016 | 5 | 0.140 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2016 | 7 | 0.140 |
Why?
| | Integrin beta Chains | 1 | 2015 | 7 | 0.140 |
Why?
| | Autistic Disorder | 2 | 2020 | 168 | 0.140 |
Why?
| | Tooth Abnormalities | 1 | 2015 | 11 | 0.140 |
Why?
| | Chronic Disease | 1 | 2022 | 1636 | 0.140 |
Why?
| | Sphingosine | 1 | 2016 | 35 | 0.140 |
Why?
| | Precision Medicine | 1 | 2019 | 363 | 0.140 |
Why?
| | Alopecia | 1 | 2015 | 34 | 0.140 |
Why?
| | Keratins, Type I | 1 | 2015 | 1 | 0.140 |
Why?
| | Transcriptome | 1 | 2021 | 756 | 0.140 |
Why?
| | Hair Diseases | 1 | 2015 | 6 | 0.130 |
Why?
| | Activating Transcription Factor 6 | 1 | 2015 | 18 | 0.130 |
Why?
| | Color Vision Defects | 1 | 2015 | 6 | 0.130 |
Why?
| | Mitral Valve Insufficiency | 1 | 2016 | 62 | 0.130 |
Why?
| | Coatomer Protein | 1 | 2015 | 3 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2016 | 68 | 0.130 |
Why?
| | Lipase | 1 | 2015 | 70 | 0.130 |
Why?
| | Cohort Studies | 4 | 2019 | 5116 | 0.130 |
Why?
| | Prevalence | 2 | 2016 | 2326 | 0.130 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2016 | 118 | 0.130 |
Why?
| | Methionine Adenosyltransferase | 1 | 2014 | 9 | 0.130 |
Why?
| | Hair | 1 | 2015 | 68 | 0.130 |
Why?
| | Transglutaminases | 1 | 2015 | 143 | 0.130 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 31 | 0.130 |
Why?
| | Contracture | 1 | 2015 | 23 | 0.130 |
Why?
| | Golgi Apparatus | 1 | 2015 | 91 | 0.130 |
Why?
| | Chromosomes, Human, Pair 16 | 2 | 2014 | 30 | 0.130 |
Why?
| | Forkhead Transcription Factors | 1 | 2016 | 182 | 0.130 |
Why?
| | Moyamoya Disease | 1 | 2014 | 15 | 0.130 |
Why?
| | Sodium Channels | 1 | 2015 | 63 | 0.130 |
Why?
| | Autoantigens | 1 | 2017 | 397 | 0.130 |
Why?
| | Principal Component Analysis | 1 | 2015 | 180 | 0.130 |
Why?
| | Genetic Heterogeneity | 1 | 2014 | 56 | 0.130 |
Why?
| | RNA Splicing | 1 | 2016 | 243 | 0.120 |
Why?
| | Labyrinth Supporting Cells | 1 | 2014 | 3 | 0.120 |
Why?
| | Microsatellite Repeats | 3 | 2018 | 143 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2016 | 454 | 0.120 |
Why?
| | Arthritis | 1 | 2015 | 112 | 0.120 |
Why?
| | Extremities | 1 | 2015 | 113 | 0.120 |
Why?
| | Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2013 | 2 | 0.120 |
Why?
| | Carrier Proteins | 2 | 2018 | 726 | 0.120 |
Why?
| | Transfer RNA Aminoacylation | 1 | 2013 | 2 | 0.120 |
Why?
| | Aging, Premature | 1 | 2013 | 11 | 0.120 |
Why?
| | Tetraspanins | 1 | 2013 | 16 | 0.120 |
Why?
| | Fatty Acids | 1 | 2016 | 407 | 0.120 |
Why?
| | Computational Biology | 2 | 2018 | 588 | 0.120 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2013 | 13 | 0.120 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2014 | 148 | 0.110 |
Why?
| | Face | 1 | 2015 | 165 | 0.110 |
Why?
| | Language Development Disorders | 1 | 2013 | 40 | 0.110 |
Why?
| | Cytoplasm | 1 | 2014 | 269 | 0.110 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 394 | 0.110 |
Why?
| | Sequence Deletion | 1 | 2013 | 171 | 0.110 |
Why?
| | Leukoencephalopathies | 1 | 2013 | 32 | 0.110 |
Why?
| | Chickens | 1 | 2013 | 185 | 0.110 |
Why?
| | GPI-Linked Proteins | 1 | 2012 | 56 | 0.110 |
Why?
| | Cell Line | 1 | 2018 | 2707 | 0.110 |
Why?
| | Neoplasm Proteins | 2 | 2017 | 401 | 0.110 |
Why?
| | Proteins | 1 | 2018 | 938 | 0.110 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 33 | 0.110 |
Why?
| | Claudins | 1 | 2012 | 24 | 0.100 |
Why?
| | Case-Control Studies | 3 | 2016 | 3171 | 0.100 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2011 | 15 | 0.100 |
Why?
| | Autoimmune Diseases | 1 | 2015 | 398 | 0.100 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 4552 | 0.100 |
Why?
| | Smad3 Protein | 1 | 2011 | 47 | 0.100 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2011 | 74 | 0.100 |
Why?
| | Population Surveillance | 1 | 2014 | 413 | 0.100 |
Why?
| | Syndrome | 2 | 2015 | 344 | 0.100 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 2013 | 28 | 0.100 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 248 | 0.100 |
Why?
| | Mitochondria | 1 | 2016 | 786 | 0.100 |
Why?
| | Logistic Models | 1 | 2016 | 1901 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2015 | 464 | 0.090 |
Why?
| | Epilepsy | 1 | 2014 | 290 | 0.090 |
Why?
| | Heterozygote | 2 | 2014 | 262 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2445 | 0.090 |
Why?
| | Software | 1 | 2014 | 613 | 0.090 |
Why?
| | DNA Mutational Analysis | 3 | 2017 | 381 | 0.080 |
Why?
| | Signal Transduction | 2 | 2019 | 4709 | 0.080 |
Why?
| | Audiometry | 2 | 2005 | 33 | 0.080 |
Why?
| | Protein Domains | 2 | 2021 | 212 | 0.080 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 1 | 2006 | 8 | 0.070 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2006 | 15 | 0.070 |
Why?
| | Audiometry, Pure-Tone | 1 | 2006 | 24 | 0.070 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2006 | 28 | 0.070 |
Why?
| | Jordan | 1 | 2005 | 3 | 0.070 |
Why?
| | Auditory Threshold | 1 | 2006 | 36 | 0.070 |
Why?
| | Risk Factors | 2 | 2016 | 9000 | 0.070 |
Why?
| | Sequence Analysis, Protein | 1 | 2005 | 31 | 0.070 |
Why?
| | Chromosome Aberrations | 1 | 2006 | 136 | 0.070 |
Why?
| | Population Dynamics | 1 | 2006 | 137 | 0.070 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2005 | 51 | 0.070 |
Why?
| | Netherlands | 1 | 2005 | 62 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2005 | 219 | 0.060 |
Why?
| | Membrane Glycoproteins | 1 | 2006 | 446 | 0.060 |
Why?
| | Nuclear Proteins | 2 | 2018 | 597 | 0.060 |
Why?
| | Linear Models | 1 | 2006 | 827 | 0.060 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 1323 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 814 | 0.060 |
Why?
| | United States | 1 | 2019 | 12555 | 0.050 |
Why?
| | Calcium-Binding Proteins | 2 | 2014 | 217 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2006 | 671 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2018 | 2680 | 0.050 |
Why?
| | Aged | 4 | 2016 | 19657 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2005 | 454 | 0.050 |
Why?
| | Fibroblasts | 2 | 2016 | 842 | 0.050 |
Why?
| | Sequence Homology | 1 | 2020 | 40 | 0.050 |
Why?
| | Movement Disorders | 1 | 2020 | 45 | 0.040 |
Why?
| | Growth Disorders | 1 | 2020 | 77 | 0.040 |
Why?
| | Embryonic Development | 1 | 2020 | 118 | 0.040 |
Why?
| | Nucleotide Mapping | 1 | 2018 | 4 | 0.040 |
Why?
| | Disease Progression | 1 | 2006 | 2490 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 30 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2016 | 4077 | 0.040 |
Why?
| | Sjogren-Larsson Syndrome | 1 | 2017 | 1 | 0.040 |
Why?
| | Ichthyosis Vulgaris | 1 | 2017 | 1 | 0.040 |
Why?
| | Porphyria, Variegate | 1 | 2017 | 1 | 0.040 |
Why?
| | Protoporphyrinogen Oxidase | 1 | 2017 | 1 | 0.040 |
Why?
| | Photosensitivity Disorders | 1 | 2017 | 7 | 0.040 |
Why?
| | Flavoproteins | 1 | 2017 | 7 | 0.040 |
Why?
| | INDEL Mutation | 1 | 2017 | 14 | 0.040 |
Why?
| | 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2017 | 3 | 0.040 |
Why?
| | Keratin-14 | 1 | 2017 | 12 | 0.040 |
Why?
| | Epidermolysis Bullosa Simplex | 1 | 2017 | 10 | 0.040 |
Why?
| | Collagen Type VII | 1 | 2017 | 13 | 0.040 |
Why?
| | Xeroderma Pigmentosum | 1 | 2017 | 8 | 0.040 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2017 | 16 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2018 | 101 | 0.040 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2017 | 32 | 0.040 |
Why?
| | Endonucleases | 1 | 2017 | 31 | 0.040 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2017 | 21 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2017 | 69 | 0.040 |
Why?
| | Blister | 1 | 2017 | 39 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1346 | 0.040 |
Why?
| | Periodontal Diseases | 1 | 2017 | 58 | 0.040 |
Why?
| | Epidermolysis Bullosa | 1 | 2017 | 41 | 0.040 |
Why?
| | Muscular Diseases | 1 | 2017 | 107 | 0.040 |
Why?
| | Genetic Complementation Test | 1 | 2016 | 62 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2674 | 0.040 |
Why?
| | Stereocilia | 1 | 2016 | 8 | 0.040 |
Why?
| | Transcription Factors | 2 | 2017 | 1570 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2014 | 2657 | 0.040 |
Why?
| | Cameroon | 1 | 2016 | 10 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2016 | 44 | 0.040 |
Why?
| | Physical Chromosome Mapping | 2 | 2006 | 16 | 0.040 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2015 | 17 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2016 | 79 | 0.030 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2015 | 63 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2005 | 4596 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 226 | 0.030 |
Why?
| | Cataract | 1 | 2018 | 194 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 109 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 55 | 0.030 |
Why?
| | Craniofacial Dysostosis | 1 | 2015 | 3 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2015 | 75 | 0.030 |
Why?
| | Introns | 1 | 2016 | 234 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 372 | 0.030 |
Why?
| | Gene Rearrangement | 1 | 2015 | 141 | 0.030 |
Why?
| | Hepatocyte Growth Factor | 1 | 2014 | 33 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2016 | 193 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2016 | 546 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 97 | 0.030 |
Why?
| | Ion Channels | 1 | 2015 | 126 | 0.030 |
Why?
| | Vascular Remodeling | 1 | 2016 | 152 | 0.030 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 236 | 0.030 |
Why?
| | Sample Size | 1 | 2014 | 133 | 0.030 |
Why?
| | GTPase-Activating Proteins | 1 | 2014 | 71 | 0.030 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 158 | 0.030 |
Why?
| | Protein Transport | 1 | 2015 | 412 | 0.030 |
Why?
| | Myosin Light Chains | 1 | 2013 | 35 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 996 | 0.030 |
Why?
| | Aorta | 1 | 2016 | 367 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2013 | 109 | 0.030 |
Why?
| | Heart Valve Diseases | 1 | 2014 | 135 | 0.030 |
Why?
| | Disease | 1 | 2014 | 98 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 241 | 0.030 |
Why?
| | Osteogenesis | 1 | 2015 | 213 | 0.030 |
Why?
| | Retina | 1 | 2015 | 278 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 495 | 0.030 |
Why?
| | Genome, Human | 1 | 2014 | 387 | 0.030 |
Why?
| | Haploinsufficiency | 1 | 2012 | 47 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2014 | 336 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 455 | 0.030 |
Why?
| | Ribose-Phosphate Pyrophosphokinase | 1 | 2011 | 1 | 0.030 |
Why?
| | Age of Onset | 1 | 2013 | 467 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2011 | 33 | 0.020 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2011 | 58 | 0.020 |
Why?
| | Neuropeptides | 1 | 2011 | 68 | 0.020 |
Why?
| | Models, Genetic | 1 | 2013 | 595 | 0.020 |
Why?
| | Aortic Valve | 1 | 2014 | 401 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1489 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2013 | 413 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 319 | 0.020 |
Why?
| | Computer Simulation | 1 | 2013 | 922 | 0.020 |
Why?
| | Actins | 1 | 2011 | 404 | 0.020 |
Why?
| | Trans-Activators | 1 | 2011 | 373 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2011 | 823 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2005 | 12978 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2011 | 565 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1158 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 3730 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2484 | 0.020 |
Why?
| | India | 1 | 2006 | 141 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3174 | 0.010 |
Why?
| | Brain | 1 | 2013 | 2490 | 0.010 |
Why?
|
|
Santos-Cortez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|